Differential regulation of human platelet responses by cGMP inhibited and stimulated cAMP phosphodiesterases

Thrombosis and Haemostasis

Volumn 87, Issue 5, 2002, Pages 873-879

  Manns, J M ^a   Brennan, K J ^a   Colman, Robert W ^a   Sheth, S B ^a  

^a TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cAMP; EHNA; Milrinone; Phosphodiesterases; Platelets

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 9 (2 HYDROXY 3 NONYL)ADENINE; ANTITHROMBOCYTIC AGENT; CALCIUM ION; COLLAGEN; CYCLIC AMP; CYCLIC AMP PHOSPHODIESTERASE; CYCLIC GMP; ISOBUTYLMETHYLXANTHINE; MILRINONE; PHOSPHODIESTERASE; PHOSPHODIESTERASE II INHIBITOR; PHOSPHODIESTERASE IIA; PHOSPHODIESTERASE III INHIBITOR; PHOSPHODIESTERASE IIIA; QUAZINONE; THROMBIN; THROMBIN RECEPTOR ACTIVATING PEPTIDE; UNCLASSIFIED DRUG; VASODILATOR STIMULATED PHOSPHOPROTEIN;

ARTICLE; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG ANTAGONISM; DRUG EFFECT; DRUG EFFICACY; DRUG EXPOSURE; DRUG POTENTIATION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME SPECIFICITY; HUMAN; HUMAN CELL; METABOLIC REGULATION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION;

EID: 0036256541     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0037-1613099     Document Type: Article

References (42)

1. Role of cyclic AMP in platelet function
2. Regulatory and catalytic domains of platelet cAMP phosphodiesterases: Targets for drug design
3. Cyclic nucleotide phosphodiesterases: Functional implications of multiple isoforms
4. Purification and characterization of a cyclic GMP-stimulated cyclic nucleotide phosphodiesterase from the cytosol of human platelets
5. Membrane localization of cyclic nucleotide phosphodiesterase 3 (PDE3). Two N-terminal Domains are required for the efficient targeting to, and association of, PDE3 with endoplasmic reticulum
6. Myomegalin is a novel protein of the golgi/centrosome that interacts with a cyclic nucleotide phosphodiesterase
7. Stoichiometric and reversible phosphorylation of a 46-kDa protein in human platelets in response to cGMP- and cAMP-elevating vasodilators
8. Facile platelet adhesion to collagen requires metabolic energy and actin polymerization and evokes intracellular free calcium mobilization
9. Analysis and regulation of vasodilator-stimulated phosphoprotein serine 239 phosphorylation in vitro and in intact cells using a phosphospecific monoclonal antibody
10. Flow cytometry analysis of intracellular VASP phosphorylation for the assessment of activating and inhibitory signal transduction pathways in human platelets - Definition and detection of ticlopidine/clopidogrel effects
11. cAMP- and cGMP-dependent protein kinase phosphorylation sites of the focal adhesion vasodilator-stimulated phosphoprotein (VASP) in vitro and in intact human platelets
12. Concentration and regulation of cyclic nucleotides, cyclic-nucleotide-dependent protein kinases and one of their major substrates in human platelets. Estimating the rate of cAMP-regulated and cGMP-regulated protein phosphorylation in intact cells
13. cAMP-mediated phosphorylation of the low-Km cAMP phosphodiesterase markedly stimulates its catalytic activity
14. Subclasses of cyclic AMP phosphodiesterase in cardiac muscle
15. Multiple molecular forms of phosphodiesterase and the regulation of cardiac muscle contractility
16. Multiple molecular forms of cyclic nucleotide phosphodiesterase in cardiac and smooth muscle and in platelets. Isolation, characterization, and effects of various reference phosphodiesterase inhibitors and cardiotonic agents
17. Role of phosphodiesterases in the regulation of endothelial permeability in vitro
18. Pharmacology of positive inotropic phosphodiesterase III inhibitors
19. Cyclic AMP-phosphodiesterase IIIA1 inhibitors decrease cytosolic Ca2+ concentration and increase the Ca2+ content of intracellular storage sites in human platelets
20. Selective inhibitors of three forms of cyclic nucleotide phosphodiesterase - Basic and potential clinical applications
21. Regulation of cyclic AMP metabolism in human platelets. Sequential activation of adenylate cyclase and cyclic AMP phosphodiesterase by prostaglandins
22. Activation of cGMP-stimulated phosphodiesterase by nitroprusside limits cAMP accumulation in human platelets: Effects on platelet aggregation
23. Pharmacological manipulation of tissue cyclic AMP by inhibitors. Effects of phosphodiesterase inhibitors on the functions of platelets and vascular endothelial cells
24. Interplay between milrinone and adenosine in the inhibition of human platelet response
25. Effects of adenosine on levels of adenosine cyclic 3′,5′-monophosphate in human blood platelets in relation to adenosine incorporation and platelet aggregation
26. cAMP compartmentation is responsible for a local activation of cardiac Ca2+ channels by beta-adrenergic agonists
27. Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes
28. cGMP-stimulated cyclic nucleotide phosphodiesterase regulates the basal calcium current in human atrial myocytes
29. Inhibition of aggregation and stimulation of cyclic AMP generation in intact human platelets by the diterpene forskolin
30. Imidazoquinoline derivatives: Potent inhibitors of platelet cAMP phosphodiesterase which elevate cAMP levels and activate protein kinase in platelets
31. The effect of selective phosphodiesterase 3 and 4 isoenzyme inhibitors and established anti-asthma drugs on inflammatory cell activation
32. Intracellular localization of the PDE4A cAMP-specific phosphodiesterase splice variant RD1 (RNPDE4A1A) in stably transfected human thyroid carcinoma FTC cell lines
33. The cAMP-specific phosphodiesterase PDE4A5 is cleaved downstream of its SH3-interaction domain by caspase-3: Consequences for altered intracellular distribution
34. Compartmentalization of cAMP signaling in mesangial cells by phosphodiesterase isozymes PDE3 and PDE4. Regulation of superoxidation and mitogenesis
35. Tailoring cAMP-signalling responses through isoform multiplicity
36. A kinase anchor proteins and the intracellular targeting of signals carried by cyclic AMP
37. The multienzyme PDE4 cyclic adenosine monophosphate-specific phosphodiesterase family: Intracellular targeting, regulation, and selective inhibition by compounds exerting antiinflammatory and antidepressant actions
38. Cyclic nucleotide-gated channels colocalize with adenylyl cyclase in regions of restricted cAMP diffusion
39. A uniform extracellular stimulus triggers distinct cAMP signals in different compartments of a simple cell
40. Isolation and regulation of the cGMP-inhibited cAMP phosphodiesterase in human erythroleukemia cells
41. Molecular basis of the synergistic inhibition of platelet function by nitrovasodilators and activators of adenylate cyclase: Inhibition of cyclic AMP breakdown by cyclic GMP
42. Evidence for platelet alphaIIb beta3 activation despite elevated cytosolic cAMP